Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
01/2006
01/03/2006CA2244695C Cyclic amic acid derivatives
12/2005
12/29/2005WO2005123709A1 Method for producing 2-oxo-1-phenyl-3-oxabicyclo[3.1.0]hexane
12/29/2005WO2005123667A1 Substituted bicyclooctenes and their use as herbicides
12/29/2005WO2005123661A1 Method for producing nitriles by elimination of water from aldehyde oximes with alkylphosphonic anhydrides
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005WO2005007625A3 Heterocyclic amides with anti-tuberculosis activity
12/29/2005US20050288519 5-Nitrobenzofurans
12/29/2005US20050288508 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents
12/29/2005US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides
12/29/2005US20050288364 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/29/2005US20050288338 Amido compounds and their use as pharmaceuticals
12/29/2005US20050288335 Triamide-substituted heterobicyclic compounds
12/29/2005US20050288329 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1119410B1 Selective oxidation process and catalyst therefor
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005EP1002790B1 Sphingosine analogues
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/28/2005CN1712400A Extraction of aromatic turmeric alcohol
12/28/2005CN1233629C Sulfolipid compound with neural nourishing function and synthetic method and application thereof
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2237910C Excitatory amino acid derivatives
12/27/2005CA2160712C Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121113A1 Novel tetracyclic tetrahydrofuran derivatives
12/22/2005WO2005121112A1 Medicinal compositions containing 6-hydroxybenz- bromarone or salts thereof
12/22/2005WO2005121111A1 Method for producing 3-aminomethyltetrahydrofuran derivative
12/22/2005WO2005121104A1 Pyridazine compound and use thereof
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005120148A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005WO2005046829B1 Separation of ginkgolides and bilobalide from g. biloba
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282898 Methods for the synthesis of milnacipran and congeners thereof
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
12/22/2005US20050282808 activated blood coagulation factor X inhibitor; 5-Dimethylaminocarbonyl-3-[4-(N-formyl-N-methylamino)cyclohexylcarbonylamino]-N-(5-chloropyridin-2-yl)benzofuran-2-carboxamide; for treatment of thrombosis; free of phospholipidosis and/or hepatotoxicity; oral administration; bioavailability
12/22/2005US20050282806 2-(4-morpholinyl)ethyl (E)-6-(1,3-dihydro-4-[2-(4-morpholinyl)ethoxy]-6-methoxy-7-methyl-3-oxo-isobenzofuran-5-yl)-4-methyl-hex-4-enoate; use as reference marker in HPLC study of pharmacology and toxicology; combining mycophenolate mofetil with 4-(2-chloroethyl)-morpholine hydrochloride
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005US20050282780 benzoxazoles derivatives such as 2-(4-Trifluoromethoxy-phenyl)-benzooxazole-5-carboxylic acid, used for the treatment of Alzheimer's disease, spongiform encephalopathy, polyneuropathy, cardiomyopathy, non-insulin dependent diabetes and medullary carcinoma of the thyroid
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568800A1 Process for producing 3-aminomethyltetrahydrofuran derivative
12/22/2005CA2567847A1 Novel tetracyclic tetrahydrofuran derivatives
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/21/2005EP1606306A2 Steroid spirolactonization
12/21/2005EP1606275A1 Opioid receptor antagonists
12/21/2005EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols
12/21/2005EP1605904A2 Reduction of hair growth
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1307445B1 Benzofuran derivatives and their use as antibacterial agents
12/21/2005EP1173265B1 Sonic impinging jet crystallization apparatus and process
12/21/2005EP0777474B1 Methods for the treatment of inflammatory joint disease
12/21/2005CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711251A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1711133A Supported catalyst containing rhenium and method for hydrogenation of carbonyl compounds in liquid phase by means of said catalyst
12/21/2005CN1709883A Method for synthesizing beta-iodobutyl lactone
12/21/2005CN1232519C Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination
12/21/2005CN1232517C Anti-cancer active substance of cyathocline purpurea and separating and purifying method thereof
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232496C Method for purifying an organic solvent for the purpose of absorption of maleic acid anhydride
12/20/2005US6977306 Citalopram hydrobromide crystal and method for crystallization thereof
12/20/2005US6977270 Tocotrienolquinone cyclization product with an anti-hypercholesterol effect
12/20/2005US6977265 Piperidine CCR-3 receptor antagonists
12/20/2005US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases
12/20/2005CA2181569C Ep2-receptor agonists as agents for lowering intraocular pressure
12/15/2005WO2005119315A2 Non-linear optically active molecules, their synthesis, and use
12/15/2005WO2005118565A1 Intermediates for the preparation of halichondrin b
12/15/2005WO2005118564A2 Methods for the synthesis of milnacipran and congeners thereof
12/15/2005WO2005118539A1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
12/15/2005WO2005118530A1 Triketone compounds, method for producing those and herbicide containing those
12/15/2005WO2005118511A2 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/15/2005WO2005117907A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/15/2005WO2005075455A3 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005CA2569238A1 Monoamine reuptake inhibitor
12/15/2005CA2567984A1 Intermediates for the preparation of analogs of halichondrin b
12/15/2005CA2565705A1 Non-linear optically active molecules, their synthesis, and use
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1603902A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments
12/14/2005EP1603893A1 Ep4 receptor antagonists
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1603555A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/14/2005EP1487575B1 Method for the production of a catalyst containing vanadium, phosphorus, and oxygen
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/14/2005EP1200411B1 Process for synthesis of heteroaryl-substituted urea compounds
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708480A Carotenoid analogs for the inhibition and amelioration of disease
12/14/2005CN1708479A Novel compounds useful in treating PPAR mediated diseases
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1231487C Metallocenes and catalysts for olefin-polymerisation
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231455C Continuously hydrogen adding method
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 472